InsidersTradesSigma
Follow the ADHERIS HEALTH LIMITED stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are quoted on AU AU, under the supervision of ASX. Market capitalisation: €10.8m. The latest transaction was filed on 1 July 2026 (Other). Among the most active insiders: John Murray Date of appointment 1 July 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
ADHERIS HEALTH LIMITED is a company listed on the XASX, specializing in the healthcare sector. It focuses on developing solutions to improve patient adherence to medical treatments.